The invention provides a method for identifying potential therapeutic agents by relating in vitro techniques for drug screening of neural cells with neural circuitry function in animals and humans. The method involves objectively measuring, in a quantifiable and reproducible manner, the effects of the agents on pain and other motivational functions.
DRUG DEVELOPMENT BY RAPID NEUROIMAGING OF NEURAL CELLS